Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

NeOnc Technologies Holdings, Inc. - Common Stock (NQ:NTHI)

4.690 +0.015 (+0.32%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 24, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 204,451
Open 4.840
Bid (Size) 4.330 (27,500)
Ask (Size) 4.980 (2,100)
Prev. Close 4.675
Today's Range 4.550 - 5.097
52wk Range 3.005 - 12.99
Shares Outstanding 19,474,303
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
New to The Street Airs This Weekend Across Bloomberg Television U.S., Latin America and MENA
From New to The Street
Via ACCESS Newswire
News headline image
Stonegate Capital Partners Updates Coverage on NeOnc Technologies Holdings, Inc. (NTHI) 2Q26
Dallas, Texas--(Newsfile Corp. - August 13, 2026) - NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI). Stonegate Capital Partners Updates Coverage on... 
Via Newsfile

Performance

YTD
-47.2%
-47.2%
1 Month
+36.3%
+36.3%
3 Month
-8.8%
-8.8%
6 Month
-50.8%
-50.8%
1 Year
-19.1%
-19.1%

More News

Read More
News headline image
NeOnc's NEO100 Phase 2a Brain Cancer Study Beats Historical Benchmark by Nearly 2.5x
Via Newsfile
News headline image
NeOnc Technologies Reports Positive Topline Phase 2a Results for Intranasal NEO100 in Recurrent IDH1-Mutant High-Grade Glioma
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
News headline image
NTHI Brain Cancer Phase 2 Data Expected to Spark Triple Confluence
Via Newsfile
News headline image
NeOnc Reports Second Quarter 2026 Financial Results and Confirms August 12 Topline Phase 2a NEO100 Data Readout
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
News headline image
NeOnc Technologies to Host Investor Conference Call to Discuss Topline Phase 2a Results for Intranasal NEO100 in Recurrent IDH1-Mutant High-Grade Glioma
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
News headline image
NeOnc Technologies Appoints Strategy and Finance Executive Nasim Shomali to its Board of Directors
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
News headline image
NeOnc Receives FDA Written Feedback on NEO212 CMC Development and Capsule-to-Tablet Transition
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
News headline image
NeOnc Technologies Receives UAE IND Approval for NEO100, Expanding Global Development Ahead of Anticipated Phase 2 Data Milestone
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
News headline image
WSTPR Catalyst Watch: Abu Dhabi Regulatory Clearance Adds Momentum to NeOnc's Global Neuro-Oncology Strategy
Via Newsfile
News headline image
NeOnc Technologies Secures UAE IND Approval for NEO212 Following Successful Phase 1 Completion, Advancing Toward Global Phase 2 Development
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
News headline image
WSTPR Catalyst Watch: NeOnc Strengthens Capital Position Ahead of Potentially Transformational Neuro-Oncology Updates
Via Newsfile
News headline image
The Race to Defeat Brain Cancer Could Become One of the Biggest Biotech Stories of the Decade
Via Newsfile
Topics Artificial Intelligence
News headline image
NeOnc Provides Business Update and Reports Q1 2026 Financial Results
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
News headline image
NeOnc CEO Accelerates Insider Buying with $500K+ Investment Ahead of Imminent NEO100 Phase 2a Data Catalysts
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
News headline image
New to The Street to Broadcast Tonight on Bloomberg at 6:30 PM EST - Show #744 Featuring Virtuix Holdings (NASDAQ:VTIX), Neonc Technologies Holdings (NASDAQ:NTHI), Medicus Pharma (NASDAQ:MDCX), YY Group Holding (NASDAQ:YYGH), and Vivos Therapeutics
Via ACCESS Newswire
News headline image
NeOnc Technologies Holdings, Inc. Announces ~ $300,000 in Insider Purchases of NTHI Stock by Chairman and CEO; Company Provides Context on 2025 Financial Results
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
News headline image
NeOnc Provides Business Update and Reports Q4 2025 Financial Results
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
News headline image
NeOnc Technologies Appoints David Choi as Chief Accounting Officer
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
News headline image
Stonegate Capital Partners Updates Coverage on NeOnc Technologies Holdings, Inc. (NTHI)
Via Newsfile
News headline image
NeOnc Technologies Reports Phase 1 Dose-Escalation Results for Dosing and Toxicity and Determination of Recommended Phase 2 Dose for Oral NEO212; Management to Host KOL Conference Call Today at 9 a.m. ET
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
News headline image
NeOnc Technologies (Nasdaq: NTHI) to Host Investor Conference Call to Present Dose-Escalation Results from Full Phase 1 NEO212-01 Readout for Dosing and Toxicity
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
News headline image
New to The Street to Broadcast Executive Leadership Interviews Tonight at 6:30 PM EST on Bloomberg Television Across the U.S., MENA and Latin America
Via ACCESS Newswire
News headline image
New to The Street to Broadcast Show #726 on Bloomberg at 6:30 PM EST Featuring Vivos Therapeutics (NASDAQ:VVOS), Aeries Technology (NASDAQ:AERT), Virtuix Holdings (NASDAQ:VTIX), and Stardust Power (NASDAQ:SDST)
Via ACCESS Newswire

Frequently Asked Questions

Is NeOnc Technologies Holdings, Inc. - Common Stock publicly traded?
Yes, NeOnc Technologies Holdings, Inc. - Common Stock is publicly traded.
What exchange does NeOnc Technologies Holdings, Inc. - Common Stock trade on?
NeOnc Technologies Holdings, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for NeOnc Technologies Holdings, Inc. - Common Stock?
The ticker symbol for NeOnc Technologies Holdings, Inc. - Common Stock is NTHI on the Nasdaq Stock Market
What is the current price of NeOnc Technologies Holdings, Inc. - Common Stock?
The current price of NeOnc Technologies Holdings, Inc. - Common Stock is 4.690
When was NeOnc Technologies Holdings, Inc. - Common Stock last traded?
The last trade of NeOnc Technologies Holdings, Inc. - Common Stock was at 08/24/26 04:00 PM ET
What is the market capitalization of NeOnc Technologies Holdings, Inc. - Common Stock?
The market capitalization of NeOnc Technologies Holdings, Inc. - Common Stock is 91.33M
How many shares of NeOnc Technologies Holdings, Inc. - Common Stock are outstanding?
NeOnc Technologies Holdings, Inc. - Common Stock has 91M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.